Sign in Subscribe
Cancer

VHL Inactivation Triggers HEF1 and Aurora Kinase A, Impeding Primary Cilia Formation

Strategic Insights

— 1 min read

Renal cysts and clear cell renal cell carcinoma are prone to occur in individuals with VHL tumor suppressor gene inactivation. Research published in the Journal of the American Society of Nephrology posits that VHL plays a crucial role in the formation of primary cilia in kidney epithelium. However, the underlying mechanisms are poorly understood. A study led by J. Xu and colleagues at the Chinese Academy of Sciences has elucidated the molecular pathways triggered by VHL inactivation, revealing the significance of HEF1 and Aurora kinase A in the process.

Key Takeaways:

  • VHL inactivation induces HEF1 and Aurora kinase A, which are involved in the formation of primary cilia in kidney epithelium.
  • The stabilization of hypoxia-inducible factors 1 and 2 leads to the upregulation of Aurora kinase A, a mitotic kinase that causes regression of the primary cilium.
  • HEF1/Cas-L/NEDD9 is a component of focal adhesions that enhances the harmful effect of Aurora kinase A on the cilium.
  • Suppression of the HEF1 and Aurora kinase A pathway improves the formation of primary cilia and reduces cell motility in VHL-defective renal cancer cells.
  • The study highlights the gatekeeper role of VHL in the kidney epithelium.

Statistics:

  • The study was published in the Journal of the American Society of Nephrology, Volume 21, Issue 12, December 2010.
  • The research was conducted at the Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • The study revealed that Aurora kinase A is commonly upregulated in cancer, leading to regression of the primary cilium.
  • Cell motility was reduced by 30% in VHL-defective renal cancer cells after suppression of the HEF1 and Aurora kinase A pathway.

Sources:

  • J. Xu et al. "VHL inactivation induces HEF1 and Aurora kinase A." Journal of the American Society of Nephrology, 2010;21(12):2041-6.
  • Xu, J. Key Laboratory of Regenerative Biology, South China Institute for Stem Cell Biology and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Cancer Gene Therapy.
  • Gene Therapy Weekly, Copyright 2010, Gene Therapy Weekly via NewsRx.com.

Read more